Keep Current with the Latest in Cell Biology Research

Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival as First-Line Treatment in Patients with HER2-Positive Advanced Gastric or Gastroesophageal...

[Merck & Co., Inc.] Merck announced that the Phase 3 KEYNOTE-811 trial evaluating KEYTRUDA®, in combination with trastuzumab and fluoropyrimidine- and platinum-containing chemotherapy met its dual primary endpoint of overall survival for the first-line treatment of patients with HER2-positive locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

Androgen Receptor Splice Variants Drive Castration-Resistant Prostate Cancer Metastasis by Activating Distinct Transcriptional Programs

[Journal Of Clinical Investigation] Investigators found that, under castrated conditions, androgen receptor (AR)-V7 strongly induced osteoblastic bone lesions, a response not observed with full-length AR overexpression.

Prostate Cancer Screening Methods Trialed in ‘Pivotal Moment’

[The Guardian] Methods of screening men for prostate cancer will be trialed in an attempt to save thousands of lives in the UK each year, in what has been hailed as a “pivotal moment” by experts.

Improved Therapeutic Effects on Vascular Intimal Hyperplasia by Mesenchymal Stem Cells Expressing MIR155HG That Function as a ceRNA for microRNA-205

[Journal of Cellular and Molecular Medicine] Researchers investigated whether lncRNA MIR155HG could improve the efficacy of MSCs in the treatment of intimal hyperplasia and to elucidate the role of the competing endogenous RNA (ceRNA).

MSCs Promote the Efferocytosis of Large Peritoneal Macrophages to Eliminate Ferroptotic Monocytes/Macrophages in the Injured Endometria

[Stem Cell Research & Therapy] Endometrial injury in intrauterine adhesion mouse model was conducted by uterine curettage and LPS injection surgery and the samples were collected at different times to detect the changes of large peritoneal macrophages and ferroptotic monocytes/macrophages.

Measurable Residual FLT3 Internal Tandem Duplication before Allogeneic Transplant for Acute Myeloid Leukemia

[Jama Oncology] In this cohort study, DNA sequencing was performed on first CR blood from patients with FLT3-internal tandem duplication AML transplanted from March 2013 to February 2019.

CircNCX1 Modulates Cardiomyocyte Proliferation through Promoting Ubiquitination of BRG1

[Cellular Signalling] The authors reported that circNCX1, the most abundant circular RNA in mammalian hearts, could affect the proliferation of murine cardiomyocytes.

Spatiotemporal ATF3 Expression Determines VSMC Fate in Abdominal Aortic Aneurysm

[Circulation Research] Genome-wide RNA sequencing analysis was performed on the aorta isolated from saline or angiotensin II–induced abdominal aortic aneurysm (AAA) mice, and activating transcription factor (ATF) 3 was identified as the potential key gene for AAA development.

Targeting Cardiomyocyte Cell Cycle Regulation in Heart Failure

[Basic Research In Cardiology] Investigators provide an overview of current knowledge on cell cycle regulation and mechanisms underlying cardiomyocyte proliferation in cases of heart failure.

Monocytes Prevent Apoptosis of iPSCs and Promote Differentiation of Kidney Organoids

[Stem Cell Research & Therapy] Differentiation of kidney organoids from human iPSCs was performed. Cell survival and autophagy were analyzed using cell counting kit 8 kit and autophagy detection kit.

ETV4 Is a Mechanical Transducer Linking Cell Crowding Dynamics to Lineage Specification

[Nature Cell Biology] Scientists found that ETS variant transcription factor 4 (ETV4) served as a molecular transducer that linked mechanical microenvironments and gene expression.

Focal Adhesion Kinase-YAP Signaling Axis Drives Drug-Tolerant Persister Cells and Residual Disease in Lung Cancer

[Nature Communications] The authors integrated studies in patient-derived and immunocompetent lung cancer models and clinical specimens obtained from patients on targeted therapy to uncover a focal adhesion kinase-YAP signaling axis that promotes residual disease during oncogenic EGFR-, ALK-, and KRAS-targeted therapies.

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

spot_img